CSS
WST icon

Cubist Systematic Strategies’s West Pharmaceutical WST Stock Holding History

Cubist Systematic Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$90K – 3633
2024
Q3 		$90K Hold
300
– – ﹤0.01% 2705
2024
Q2 		$98.8K Sell
300
-500
-63% -$177K ﹤0.01% 2631
2024
Q1 		$317K Hold
800
– – ﹤0.01% 2853
2023
Q4 		$282K Buy
+800
New +$283K ﹤0.01% 2819
2023
Q1 		– Sell
-4,200
Closed -$988K – 4490
2022
Q4 		$988K Buy
4,200
+600
+17% +$142K 0.01% 2463
2022
Q3 		$886K Buy
+3,600
New +$1.1M 0.01% 2722

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Cubist Systematic Strategies's WST Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 24,364 shares — an estimated $9.01M sold.

Cubist Systematic Strategies first reported a position in WST in Q2 2014 and held it in 32 quarters. The position peaked at $19.4M in Q3 2022. 779 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 24,364 West Pharmaceutical shares in Q1 2024, an estimated $9.01M.
  • Cubist Systematic Strategies first reported a position in West Pharmaceutical in Q2 2014 and held it in 32 quarters.
  • Cubist Systematic Strategies's West Pharmaceutical position peaked at $19.4M in Q3 2022.
  • 779 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.